EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma
Targeted degradation of EP300 with a novel PROTAC agent in neuroblastoma cells was found to cause widespread loss of gene expression and cell death in vitro and in vivo.